AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

implement process innovation and drive your product from manufacture to market. That’s why the 2019 Cell and Gene Therapy Manufacturing Forum is our biggest yet. With content from over 18 ...

The discussion of bioprocess innovation has traditionally focused on high-throughput analytics, machine learning, and automation but less so on the systems that capture the data they generate, ...

A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense challenge for patients, managing the emotional, logistical and personal burdens ...

Automated cell ... therapy program for Parkinson’s disease. Under the terms of the agreement, Aspen will integrate Mytos’ iDEM automated cell technology into its 22,000-square-foot ...

CDMO Rentschler Biopharma is moving out of the cell and gene therapy space and putting more ... Beyond that expansion, Rentschler added a new production line at its site in Milford, Massachusetts ...

After 14 years of cancer treatment, and with few options left, CAR T-cell therapy puts a patient lymphoma into remission.